Product Images Octreotide Acetate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Octreotide Acetate NDC 25021-466 by Sagent Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text seems to be a chemical compound's formula consisting of amino acids. Specifically, it is the formula for H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol which includes 10 amino acids. The additional characters "xCH;COOH where 14t02.5" are not clear and may be an error in the .*
The text describes a medication with the National Drug Code (NDC) 25021-466-05 named Octreotide Acetate Injection. It contains 1 milligram (mcg) per 5 milliliters (mL), which is equivalent to 200 micrograms per milliliter (mL).*
This appears to be a product description for a 5,000 mg/mL multi-dose vial of octreotide acetate injection for subcutaneous injection, with an NDC number of 25021-467-05. The document also includes some seemingly unrelated text that does not appear to be relevant or understandable, likely due to errors in (optical character recognition) processing.*
This is a description of Octreotide Acetate Injection, a pharmaceutical product that comes in a 1 mL Single-Dose Vial, produced by SAGENT Pharmaceuticals. It is meant for subcutaneous injection and contains 1 mcg (base) per mL. The product is made in Canada and the packaging contains the NDC code 25021-463-01. However, there is a typo in the first line where there is a space between the "&" and "nly" which could indicate that there may have been some formatting errors during the process.*
This is a description of a pharmaceutical product, specifically a 1 mL single-dose vial of Octreotide Acetate Injection with a concentration of 100 mcg (base) per mL. The NDC number is 25021-464-01, and the product is made in Canada by an unknown pharmaceutical company that was manufactured for SAGENT. The text also includes instructions to discard unused portions.*
NDC 25021-465-01 is a prescription drug indicated for subcutaneous injection. It contains Octreotide Acetate Injection at a concentration of 500 mcg (base) per mL. The drug is a pharmaceutical product manufactured in Canada and it is available in a single-dose vial of 1 mL. No additional information can be provided due to the presence of non-English characters in the output.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.